CoChat

Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice

Open access
Xie, Kan, Fuchs, Helmut, Scifo, Enzo, Liu, Dan, Aziz, Ahmad, Aguilar-Pimentel, Juan Antonio, Amarie, Oana Veronica, Becker, Lore, da Silva-Buttkus, Patricia, Calzada-Wack, Julia, Cho, Yi-Li, Deng, Yushuang, Edwards, A. Cole, Garrett, Lillian, Georgopoulou, Christina, Gerlini, Raffaele, Hölter, Sabine M., Klein-Rodewald, Tanja, Kramer, Michael, Leuchtenberger, Stefanie, Lountzi, Dimitra, Mayer-Kuckuk, Phillip, Nover, Lena L., Oestereicher, Manuela A., Overkott, Clemens, Pearson, Brandon L., Rathkolb, Birgit, Rozman, Jan, Russ, Jenny, Schaaf, Kristina, Spielmann, Nadine, Sanz-Moreno, Adrián, Stoeger, Claudia, Treise, Irina, Bano, Daniele, Busch, Dirk H., Graw, Jochen, Klingenspor, Martin, Klopstock, Thomas, Mock, Beverly A., Salomoni, Paolo, Schmidt-Weber, Carsten, Weiergräber, Marco, Wolf, Eckhard, Wurst, Wolfgang, Gailus-Durner, Valérie, Breteler, Monique M. B., Hrabě de Angelis, Martin, Ehninger, Dan · 2022 · Nature Communications

Published version of a preprint

Cited by 41

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Current concepts regarding the biology of aging are primarily based on studies aimed at identifying factors regulating lifespan. However, lifespan as a sole proxy measure for aging can be of limited value because it may be restricted by specific pathologies. Here, we employ large-scale phenotyping to analyze hundreds of markers in aging male C57BL/6J mice. For each phenotype, we establish lifetime profiles to determine when age-dependent change is first detectable relative to the young adult baseline. We examine key lifespan regulators (putative anti-aging interventions; PAAIs) for a possible countering of aging. Importantly, unlike most previous studies, we include in our study design young treated groups of animals, subjected to PAAIs prior to the onset of detectable age-dependent phenotypic change. Many PAAI effects influence phenotypes long before the onset of detectable age-dependent change, but, importantly, do not alter the rate of phenotypic change. Hence, these PAAIs have limited effects on aging.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-022-34515-y

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 108

  1. Barardo, D. et al. The DrugAge database of aging-related drugs. Aging Cell 16, 594–597 (2017). · DOI · Paper page
  2. Miller, R.A. Biology of Aging and Longevity. In: Hazzard’s Geriatric Medicine and Gerontology (eds. Halter, J.B. et al.) (McGraw Hill, 2009).
  3. Pettan-Brewer, C. & Treuting, P. M. Practical pathology of aging mice. Pathobiol. Aging Age-Relat. Dis. 1, 7202 (2011). · DOI · Paper page
  4. Brayton, C. F., Treuting, P. M. & Ward, J. M. Pathobiology of aging mice and GEM: background strains and experimental design. Vet. Pathol. 49, 85–105 (2012). · DOI · Paper page
  5. Lipman, R., Galecki, A., Burke, D. T. & Miller, R. A. Genetic loci that influence cause of death in a heterogeneous mouse stock. J. Gerontol. A Biol. Sci. Med Sci. 59, 977–983 (2004). · DOI · Paper page
  6. Miller, R. A. et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. J. Gerontol. A Biol. Sci. Med Sci. 66, 191–201 (2011). · DOI · Paper page
  7. Xie, K. et al. Every-other-day feeding extends lifespan but fails to delay many symptoms of aging in mice. Nat. Commun. 8, 155 (2017). · DOI · Paper page
  8. Rose, M. R. Evolutionary biology of aging, (Oxford University Press, Oxford, 1991).
  9. Aspinall, R. Aging of the Organs and Systems, (Kluwer Academic Publishers, 2003). · DOI
  10. Freund, A. Untangling Aging Using Dynamic, Organism-Level Phenotypic Networks. Cell Syst. 8, 172–181 (2019). · DOI
  11. Bellantuono, I. et al. A toolbox for the longitudinal assessment of healthspan in aging mice. Nat. Protoc. 15, 540–574 (2020). · DOI · Paper page
  12. Ehninger, D., Neff, F. & Xie, K. Longevity, aging and rapamycin. Cell Mol. Life Sci. 71, 4325–4346 (2014). · DOI · Paper page
  13. Richardson, A. & McCarter, R. Mechanism of food restriction: change of rate or change of set point. In: The potential for nutritional modulation of aging processes (eds. Ingram, D. K., Baker, G. T. & Shock, N. W.) 177–192 (Food & Nutrition Press, Inc., 1992).
  14. Meszaros, L., Hoffmann, A., Wihan, J. & Winkler, J. Current Symptomatic and Disease-Modifying Treatments in Multiple System Atrophy. Int. J. Mol. Sci. 21, 2775 (2020). · DOI
  15. Hampel, H. et al. Biomarkers for Alzheimer’s disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Disco. 9, 560–574 (2010). · DOI · Paper page
  16. Espay, A. & Stecher, B. Symptomatic vs. Disease-Modifying Therapies. in Brain Fables: The Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer Them 87–93 (Cambridge University Press, 2020). · DOI
  17. Kapahi, P. et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885–890 (2004). · DOI · Paper page
  18. Jia, K., Chen, D. & Riddle, D. L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131, 3897–3906 (2004). · DOI · Paper page
  19. Pan, K. Z. et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell 6, 111–119 (2007). · DOI · Paper page
  20. Bjedov, I. et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. 11, 35–46 (2010). · DOI · Paper page
  21. Anisimov, V. N. et al. Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice. Cell Cycle 10, 4230–4236 (2011). · DOI · Paper page
  22. Zhang, Y. et al. Rapamycin Extends Life and Health in C57BL/6 Mice. J. Gerontol. A Biol. Sci. Med Sci. 69, 119–130 (2014). · DOI · Paper page
  23. Wu, J. J. et al. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep. 4, 913–920 (2013). · DOI · Paper page
  24. Miller, R. A. et al. Rapamycin-Mediated Lifespan Increase in Mice is Dose and Sex-Dependent and Appears Metabolically Distinct from Dietary Restriction. Aging Cell 13, 468–477 (2014). · DOI · Paper page
  25. Fok, W. C. et al. Mice fed rapamycin have an increase in lifespan associated with major changes in the liver transcriptome. PLoS One 9, e83988 (2014). · DOI · Paper page
  26. Arriola Apelo, S. I., Pumper, C. P., Baar, E. L., Cummings, N. E. & Lamming, D. W. Intermittent Administration of Rapamycin Extends the Life Span of Female C57BL/6J Mice. J. Gerontol. A Biol. Sci. Med Sci. 71, 876–881 (2016). · DOI · Paper page
  27. Wang, T. et al. Epigenetic aging signatures in mice livers are slowed by dwarfism, calorie restriction and rapamycin treatment. Genome Biol. 18, 57 (2017). · DOI · Paper page
  28. Schinaman, J. M., Rana, A., Ja, W. W., Clark, R. I. & Walker, D. W. Rapamycin modulates tissue aging and lifespan independently of the gut microbiota in Drosophila. Sci. Rep. 9, 7824 (2019). · DOI · Paper page
  29. Ferrara-Romeo, I. et al. The mTOR pathway is necessary for survival of mice with short telomeres. Nat. Commun. 11, 1168 (2020). · DOI · Paper page
  30. Strong, R. et al. Rapamycin-mediated mouse lifespan extension: Late-life dosage regimes with sex-specific effects. Aging Cell 19, e13269 (2020). · DOI · Paper page
  31. Kenyon, C., Chang, J., Gensch, E., Rudner, A. & Tabtiang, R. A C. elegans mutant that lives twice as long as wild type. Nature 366, 461–464 (1993). · DOI · Paper page
  32. Friedman, D. B. & Johnson, T. E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 118, 75–86 (1988). · DOI · Paper page
  33. Flurkey, K., Papaconstantinou, J. & Harrison, D. E. The Snell dwarf mutation Pit1(dw) can increase life span in mice. Mech. Ageing Dev. 123, 121–130 (2002). · DOI · Paper page
  34. Ikeno, Y., Bronson, R. T., Hubbard, G. B., Lee, S. & Bartke, A. Delayed occurrence of fatal neoplastic diseases in ames dwarf mice: correlation to extended longevity. J. Gerontol. A Biol. Sci. Med Sci. 58, 291–296 (2003). · DOI · Paper page
  35. Ikeno, Y. et al. Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A Biol. Sci. Med Sci. 64, 522–529 (2009). · DOI · Paper page
  36. Masternak, M. M., Panici, J. A., Bonkowski, M. S., Hughes, L. F. & Bartke, A. Insulin sensitivity as a key mediator of growth hormone actions on longevity. J. Gerontol. A Biol. Sci. Med Sci. 64, 516–521 (2009). · DOI · Paper page
  37. Sun, L.Y. et al. Longevity is impacted by growth hormone action during early postnatal period. Elife 6, e24059 (2017). · DOI · Paper page
  38. Mattison, J. A. et al. Studies of aging in ames dwarf mice: Effects of caloric restriction. J. Am. Aging Assoc. 23, 9–16 (2000).
  39. Brown-Borg, H. M. et al. Growth hormone signaling is necessary for lifespan extension by dietary methionine. Aging Cell 13, 1019–1027 (2014). · DOI · Paper page
  40. Aguiar-Oliveira, M. H. & Bartke, A. Growth Hormone Deficiency: Health and Longevity. Endocr. Rev. 40, 575–601 (2019). · DOI · Paper page
  41. Vitale, G., Pellegrino, G., Vollery, M. & Hofland, L. J. ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights From a Centenarians’ Perspective. Front Endocrinol. (Lausanne) 10, 27 (2019). · DOI · Paper page
  42. Lamming, D. W. Extending Lifespan by Inhibiting the Mechanistic Target of Rapamycin (mTOR). In: Anti-aging Drugs: From Basic Research to Clinical Practice (ed. Vaiserman, A.M.) 352-375 (The Royal Society of Chemistry, 2017). · DOI
  43. Zhang, S. et al. Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production. Blood 117, 1228–1238 (2011). · DOI · Paper page
  44. Zhang, S. et al. B cell-specific deficiencies in mTOR limit humoral immune responses. J. Immunol. 191, 1692–1703 (2013). · DOI
  45. Eicher, E. M. & Beamer, W. G. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. J. Hered. 67, 87–91 (1976). · DOI · Paper page
  46. Flurkey, K., Papaconstantinou, J., Miller, R. A. & Harrison, D. E. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl Acad. Sci. USA 98, 6736–6741 (2001). · DOI · Paper page
  47. Ward, D. D. et al. Association of retinal layer measurements and adult cognitive function: A population-based study. Neurology 95, e1144–e1152 (2020). · DOI
  48. Someya, S. et al. Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proc. Natl Acad. Sci. USA 106, 19432–19437 (2009). · DOI · Paper page
  49. Henson, S. M. & Aspinall, R. Aging and the Immune System. In: Aging of Organs and Systems (ed. Aspinall, R.) 225-242 (Kluwer Academic Publishers, 2003). · DOI
  50. Linton, P. J. & Dorshkind, K. Age-related changes in lymphocyte development and function. Nat. Immunol. 5, 133–139 (2004). · DOI · Paper page
  51. Dorshkind, K., Montecino-Rodriguez, E. & Signer, R. A. The ageing immune system: is it ever too old to become young again? Nat. Rev. Immunol. 9, 57–62 (2009). · DOI · Paper page
  52. Bonda, T. A. et al. Remodeling of the intercalated disc related to aging in the mouse heart. J. Cardiol. 68, 261–268 (2016). · DOI
  53. Mason, J. W. et al. Electrocardiographic reference ranges derived from 79,743 ambulatory subjects. J. Electrocardiol. 40, 228–234 (2007). · DOI · Paper page
  54. Wilkinson, J. E. et al. Rapamycin slows aging in mice. Aging Cell 11, 675–682 (2012). · DOI · Paper page
  55. Bartke, A. Growth Hormone and Aging: Updated Review. World J. Mens. Health 37, 19–30 (2019). · DOI · Paper page
  56. Bartke, A. & Quainoo, N. Impact of Growth Hormone-Related Mutations on Mammalian Aging. Front Genet 9, 586 (2018). · DOI · Paper page
  57. Kim, S. S. & Lee, C. K. Growth signaling and longevity in mouse models. BMB Rep. 52, 70–85 (2019). · DOI
  58. Carrie, I., Debray, M., Bourre, J. M. & Frances, H. Age-induced cognitive alterations in OF1 mice. Physiol. Behav. 66, 651–656 (1999). · DOI
  59. Shan, T. et al. Adipocyte-specific deletion of mTOR inhibits adipose tissue development and causes insulin resistance in mice. Diabetologia 59, 1995–2004 (2016). · DOI · Paper page
  60. Selman, C. Dietary restriction and the pursuit of effective mimetics. Proc. Nutr. Soc. 73, 260–270 (2014). · DOI
  61. Speakman, J. R. & Mitchell, S. E. Caloric restriction. Mol. Asp. Med 32, 159–221 (2011). · DOI · Paper page
  62. Bordner, K. A. et al. Parallel declines in cognition, motivation, and locomotion in aging mice: association with immune gene upregulation in the medial prefrontal cortex. Exp. Gerontol. 46, 643–659 (2011).
  63. Sprott, R. L. & Eleftheriou, B. E. Open-field behavior in aging inbred mice. Gerontologia 20, 155–162 (1974). · DOI
  64. Alderman, J. M. et al. Neuroendocrine inhibition of glucose production and resistance to cancer in dwarf mice. Exp. Gerontol. 44, 26–33 (2009). · DOI
  65. Keshavarz, M., Xie, K., Schaaf, K., Bano, D. & Ehninger, D. Targeting the “hallmarks of aging” to slow aging and treat age-related disease: fact or fiction? Mol. Psychiatry https://doi.org/10.1038/s41380-022-01680-x (2022). · DOI · Paper page
  66. Blagosklonny, M. V. Validation of anti-aging drugs by treating age-related diseases. Aging 1, 281–288 (2009). · DOI · Paper page
  67. Blagosklonny, M. V. Rapamycin and quasi-programmed aging: four years later. Cell Cycle 9, 1859–1862 (2010). · DOI · Paper page
  68. Xiang, L. & He, G. Caloric restriction and antiaging effects. Ann. Nutr. Metab. 58, 42–48 (2011). · DOI
  69. Blagosklonny, M. V. Prospective treatment of age-related diseases by slowing down aging. Am. J. Pathol. 181, 1142–1146 (2012). · DOI
  70. Sohal, R. S. & Forster, M. J. Caloric restriction and the aging process: a critique. Free Radic. Biol. Med 73, 366–382 (2014). · DOI · Paper page
  71. Blagosklonny, M. V. From rapalogs to anti-aging formula. Oncotarget 8, 35492–35507 (2017). · DOI · Paper page
  72. Klimova, B., Novotny, M. & Kuca, K. Anti-Aging Drugs - Prospect of Longer Life? Curr. Med Chem. 25, 1946–1953 (2018). · doi:10.2174/0929867325666171129215251
  73. Mueller, L. D., Rauser, C. L. & Rose, M. R. Aging Stops: Late Life, Evolutionary Biology, and Gerontology. In: Does Aging Stop? (Oxford University Press, New York, 2011). · doi:10.1093/acprof:oso/9780199754229.001.0001
  74. Petr, M. A. et al. A cross-sectional study of functional and metabolic changes during aging through the lifespan in male mice. Elife 10, e62952 (2021). · DOI · Paper page
  75. Fischer, K. E. et al. A cross-sectional study of male and female C57BL/6Nia mice suggests lifespan and healthspan are not necessarily correlated. Aging (Albany NY) 8, 2370–2391 (2016). · DOI · Paper page
  76. Hayflick, L. When does aging begin? Res Aging 6, 99–103 (1984). · doi:10.1177/0164027584006001005
  77. Papadopoli, D. et al. mTOR as a central regulator of lifespan and aging. F1000Res. 8 https://doi.org/10.12688/f1000research.17196.1 (2019). · DOI · Paper page
  78. Martineau, C. N., Brown, A. E. X. & Laurent, P. Multidimensional phenotyping predicts lifespan and quantifies health in Caenorhabditis elegans. PLoS Comput Biol. 16, e1008002 (2020). · DOI
  79. Zhang, W. B. et al. Extended Twilight among Isogenic C. elegans Causes a Disproportionate Scaling between Lifespan and Health. Cell Syst. 3, 333–345 e334 (2016). · DOI · Paper page
  80. Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med Sci. 56, M146–M156 (2001). · DOI · Paper page
  81. Xie, K. et al. Epigenetic alterations in longevity regulators, reduced life span, and exacerbated aging-related pathology in old father offspring mice. Proc. Natl Acad. Sci. USA 115, E2348–E2357 (2018). · DOI · Paper page
  82. Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med Sci. 69(Suppl 1), S4–S9 (2014). · DOI · Paper page
  83. Mair, W., Goymer, P., Pletcher, S. D. & Partridge, L. Demography of dietary restriction and death in Drosophila. Science 301, 1731–1733 (2003). · DOI · Paper page
  84. Hughes, B. G. & Hekimi, S. Different Mechanisms of Longevity in Long-Lived Mouse and Caenorhabditis elegans Mutants Revealed by Statistical Analysis of Mortality Rates. Genetics 204, 905–920 (2016). · DOI · Paper page
  85. Hahm, J. H. et al. C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat. Commun. 6, 8919 (2015). · DOI · Paper page
  86. Zhao, Y. et al. Two forms of death in ageing Caenorhabditis elegans. Nat. Commun. 8, 15458 (2017). · DOI
  87. Podshivalova, K., Kerr, R. A. & Kenyon, C. How a Mutation that Slows Aging Can Also Disproportionately Extend End-of-Life Decrepitude. Cell Rep. 19, 441–450 (2017). · DOI · Paper page
  88. Stroustrup, N. et al. The temporal scaling of Caenorhabditis elegans ageing. Nature 530, 103–107 (2016). · DOI · Paper page
  89. Cohen, A. A., Levasseur, M., Raina, P., Fried, L. P. & Fulop, T. Is Aging Biology Ageist? J. Gerontol. A Biol. Sci. Med Sci. 75, 1653–1655 (2020). · DOI
  90. Le Couteur, D. G. & Simpson, S. J. Adaptive senectitude: the prolongevity effects of aging. J. Gerontol. A Biol. Sci. Med Sci. 66, 179–182 (2011). · DOI
  91. Fuchs, H. et al. Mouse phenotyping. Methods 53, 120–135 (2011). · DOI
  92. Gailus-Durner, V. et al. Systemic first-line phenotyping. Methods Mol. Biol. 530, 463–509 (2009). · DOI · Paper page
  93. Jones, B. J. & Roberts, D. J. A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 259, 211 (1968). · DOI
  94. Schoensiegel, F. et al. High throughput echocardiography in conscious mice: training and primary screens. Ultraschall Med 32(Suppl 1), S124–S129 (2011).
  95. Roth, D. M., Swaney, J. S., Dalton, N. D., Gilpin, E. A. & Ross, J. Jr. Impact of anesthesia on cardiac function during echocardiography in mice. Am. J. Physiol. Heart Circ. Physiol. 282, H2134–H2140 (2002). · DOI · Paper page
  96. Fischer, M. D. et al. Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One 4, e7507 (2009). · DOI · Paper page
  97. Schmucker, C. & Schaeffel, F. In vivo biometry in the mouse eye with low coherence interferometry. Vis. Res 44, 2445–2456 (2004). · doi:10.1016/j.visres.2004.05.018
  98. Prusky, G. T., Alam, N. M., Beekman, S. & Douglas, R. M. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol. Vis. Sci. 45, 4611–4616 (2004). · DOI · Paper page
  99. Rathkolb, B. et al. Blood Collection from Mice and Hematological Analyses on Mouse Blood. Curr. Protoc. Mouse Biol. 3, 101–119 (2013). · DOI
  100. Weaver, J. L., Broud, D. D., McKinnon, K. & Germolec, D. R. Serial phenotypic analysis of mouse peripheral blood leukocytes. Toxicol. Mech. Methods 12, 95–118 (2002). · DOI
  101. Roederer, M., Nozzi, J. L. & Nason, M. C. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytom. A 79, 167–174 (2011). · DOI · Paper page
  102. Baumgarth, N. & Roederer, M. A practical approach to multicolor flow cytometry for immunophenotyping. J. Immunol. Methods 243, 77–97 (2000). · DOI · Paper page
  103. Hou, Z. et al. A cost-effective RNA sequencing protocol for large-scale gene expression studies. Sci. Rep. 5, 9570 (2015). · DOI · Paper page
  104. Lawrence, M., Gentleman, R. & Carey, V. rtracklayer: an R package for interfacing with genome browsers. Bioinformatics 25, 1841–1842 (2009). · DOI · Paper page
  105. Li, Y., Tomko, R. J. Jr. & Hochstrasser, M. Proteasomes: Isolation and Activity Assays. Curr. Protoc. Cell Biol. 67, 3 43 41–43 43 20 (2015). · DOI
  106. Driver, A. S., Kodavanti, P. R. & Mundy, W. R. Age-related changes in reactive oxygen species production in rat brain homogenates. Neurotoxicol Teratol. 22, 175–181 (2000). · DOI · Paper page
  107. Aziz, N. A. et al. Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany. Nat. Commun. 12, 2117 (2020). · DOI
  108. Estrada, S. et al. FatSegNet: A fully automated deep learning pipeline for adipose tissue segmentation on abdominal dixon MRI. Magn. Reson Med 83, 1471–1483 (2020). · DOI

Cited by

See all 41

Metadata

Authors
Xie, K., Fuchs, H., Scifo, E., Liu, D., Aziz, A., Aguilar-Pimentel, J. A., Amarie, O. V., Becker, L., da Silva-Buttkus, P., Calzada-Wack, J., Cho, Y.-L., Deng, Y., Edwards, A. C., Garrett, L., Georgopoulou, C., Gerlini, R., Hölter, S. M., Klein-Rodewald, T., Kramer, M., Leuchtenberger, S., Lountzi, D., Mayer-Kuckuk, P., Nover, L. L., Oestereicher, M. A., Overkott, C., Pearson, B. L., Rathkolb, B., Rozman, J., Russ, J., Schaaf, K., Spielmann, N., Sanz-Moreno, A., Stoeger, C., Treise, I., Bano, D., Busch, D. H., Graw, J., Klingenspor, M., Klopstock, T., Mock, B. A., Salomoni, P., Schmidt-Weber, C., Weiergräber, M., Wolf, E., Wurst, W., Gailus-Durner, V., Breteler, M. M. B., Hrabě de Angelis, M., & Ehninger, D.
Venue
Nature Communications
Published
2022-11-11
Volume
13
Issue
1
Pages
6830-6830
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4309076141
Cited by
41
References
25
FWCI
2.35
Type
journal article
Language
en
Open access
gold
Licence
Funders
Helmholtz Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice. https://app.cochat.ai/papers/10.1038/s41467-022-34515-y
The paper
Xie, K., Fuchs, H., Scifo, E., Liu, D., Aziz, A., Aguilar-Pimentel, J. A., Amarie, O. V., Becker, L., da Silva-Buttkus, P., Calzada-Wack, J., Cho, Y.-L., Deng, Y., Edwards, A. C., Garrett, L., Georgopoulou, C., Gerlini, R., Hölter, S. M., Klein-Rodewald, T., Kramer, M., . . . Ehninger, D. (2022). Deep phenotyping and lifetime trajectories reveal limited effects of longevity regulators on the aging process in C57BL/6J mice. Nature Communications. https://doi.org/10.1038/s41467-022-34515-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.